<DOC>
	<DOCNO>NCT01274065</DOCNO>
	<brief_summary>There common rule drug affect patient . This due effect specific DNA sequence gene drug response , effect medication metabolize . The primary objective research optimize medication therapy reduce number medication use , specifically medication people developmental disability co-occur psychiatric illness .</brief_summary>
	<brief_title>Developing Interdisciplinary Pharmacogenomic Treatment Approach Reduce Medication Burden Improve Outcomes</brief_title>
	<detailed_description>The primary goal study develop process utilize pharmacogenomic analysis strategy improve quality life , safety , decrease medication burden , enhance effectiveness medication people psychiatric illness developmental disability . Ultimately , inter-disciplinary service could develop standard screen consultation tool healthcare provider utilize determine appropriate medication patient .</detailed_description>
	<mesh_term>Developmental Disabilities</mesh_term>
	<criteria>Current resident South Dakota Developmental Center ( SDDC ) Currently take high number medication per month Eligibility subject determine treatment team consist 34 follow individual : treat psychologist , behavior therapist , case manager , supervisor , counselor , dietitian , physician assistant , occupational therapist , physical therapist To determine research staff</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>psychiatry</keyword>
	<keyword>psychiatric illness</keyword>
	<keyword>developmental disability</keyword>
	<keyword>mental health</keyword>
	<keyword>medication burden</keyword>
</DOC>